The Biden administration is nothing, if not ineffective.
This has been true time and time again, as President Joe Biden continues to build his reputation as one of the most reluctant leaders that our nation has ever seen.
Just this week, Biden revealed on a conference call with state governors that the federal government would no longer be prioritizing COVID response, and that the onus would be on them to stop the global pandemic.
Then, almost unbelievably, Biden arranged for a photo op on a Delaware beach with his new puppy.
This week saw more of the same as well, with the administration now making major adjustments as to how Americans will be able to treat COVID.
President Joe Biden continues ignoring state demands for more monoclonal antibody treatments, as shortages are preventing Americans seeking the treatment from accessing them.
Last week, the Biden administration paused shipments of the Regeneron and Eli Lilly treatments because of concerns about their effectiveness against the omicron variant.
The monoclonal antibody treatment Sotrovimab continues to be distributed.
Local leaders were furious.
Florida Surgeon General Joseph Ladapo directly criticized the administration in a letter on Tuesday for “actively preventing” distribution of the treatments, noting they could be used in delta variant cases of the virus.
“The sudden suspension of multiple monoclonal antibody therapy treatments from distribution to Florida removes a health care provider’s ability to decide the best treatment options for their patients in their state,” the letter read, criticizing the “shortsightedness” of the Biden administration.
This latest lapse of judgement regarding COVID has many Americans wondering just how Biden, and the nation at large, are going to survive his first term in office.
